Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single low-dose insulin infiltration to reduce cutaneous scarring after breast reduction surgery
2005-001259-39Phase 2Completed
- Sponsor
- West Hertfordshire Teaching Hospitals NHS Trust
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of human insulin in Hypertrophic Scar (HS) (2 arms), sponsored by West Hertfordshire Teaching Hospitals NHS Trust. Primary endpoint: Reduction in postoperative cutaneous scarring severity. Started Jun 2005; status: completed.
02
Drugs
human insulin
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on 2005-001259-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001259-39.